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Monoclonal antibodies that recognize "rheumatic" antigens of peripheral blood non-T
cells were used to study the compartmentalization of such cells in peripheral blood and
tonsils of individuals with rheumatic heart disease (RHD) and suitable control subjects.
The peripheral blood of most (710/0) of the 42 individuals with RHD contained cells reacting
with monoclonal antibody 83S19.23 or 256S.l0, whereas these cells were present in only
17% of the 41 control subjects (P < .02). However, none of 21 individuals with RHD
had such cells in their tonsils, although they were present in the tonsils of 50% of the
40 control subjects (P< .03). These results may reflect a failure in RHD of organ-specific
homing of cells with the epitopes recognized by the antibodies. The presence of these
cells in tonsils may be important in the immune response to streptococcal pharyngeal
infection, and their absence in RHD may be involved in the unusual immune responses
characteristic of this disease.
Elements of the cell surfaces of some peripheral
blood mononuclear cells from individuals with a his-
tory of rheumatic fever (RF) appear to be antigeni-
cally distinct from those of the majority of the popu-
lation [1]. This difference has been defined with
human alloantisera that react with non-T cells (those
not possessing a receptor for sheep red blood cells
[SRBCs]) of >750/0 of individuals who have had
documented RF. Monoclonal antibodies with simi-
lar specificities have been developed that also allow
the definition of "rheumatic" antigens on non-T cells
[2, 3] in a similar proportion of individuals having
had RF. Previous studies of the distribution of these
antigens have examined their presence on the
mononuclear cells of peripheral blood. The present
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study was directed at their distribution in both pe-
ripheral blood and tonsils in individuals having in-
active rheumatic heart disease (RHD) compared with
those having recurrent or chronic tonsillitis.
Subjects and Methods
The individuals with RHD and control subjects were
residents of Cairo. RHD was diagnosed by careful
history and physical examination. None of the indi-
viduals with RHD had heart failure or showed signs
of rheumatic activity (i.e., fever or elevated erythro-
cyte sedimentation rate) within a year of the study,
and none showed obvious signs of nutritional defi-
ciency.
Detailed history and physical examination of the
control subjects excluded past or present RF or
RHD. The average ± SD age of those with RHD
was 11.4 ± 2.5 years and of the control subjects, 9.8
± 4.8 years (difference not significant). Samples of
peripheral blood and tonsillar tissue were obtained
from individuals undergoing tonsillectomy on the
advice of their physician. The indication cited for
tonsillectomy was recurrent or chronic tonsillitis. The
subjects were afebrile and had normal erythrocyte
sedimentation rates. The individuals with RHD had
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approximately two incidents of pharyngitis during
the year before study, whereas the control subjects
had six incidents. Each tonsil was cultured and ex-
amined for the presence of group A Streptococcus.
The recovery of this organism was infrequent and
not different in the RHO and control groups. This
finding was consistent with the attending physicians'
reports that all of the volunteers had taken penicil-
lin or sulfonamides for at least one month before
tonsillectomy. Some of the individuals with RHD
either had already undergone tonsillectomy or were
not scheduled for this operation, so only blood was
studied from this group.
Mononuclear cells were isolated from blood and
tonsils by gradient centrifugation. Mononuclear cells
were rosetted with SRBCs, and T cells were separated
from non-T cells by gradient centrifugation as pre-
viously described [4, 5]. The blood was diluted with
an equal volume of Eagle's MEM, layered on Ficoll-
Paque" (Pharmacia, Uppsala, Sweden), and cen-
trifuged at 650 g for 30 min. The mononuclear cells
were removed from the gradient interface and washed
twice with MEM, and a portion was subjected to ro-
sette depletion for removal of T lymphocytes. The
tonsils were minced with scissors and shaken for 1
min with MEM. Mononuclear cells were isolated
from the resulting cell suspension by the same
method used with blood. T cell depletion was ac-
complished by SRBC rosetting. The mononuclear
cells from blood and tonsils were resuspended in
MEM containing 20070 fetal calf serum (previously
adsorbed with SRBCs) and then incubated for 5 min
Table 1. Immunofluorescence assay of "rheumatic" cells.
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at 37 C with an equal volume of 5070 SRBCs in 20070
adsorbed fetal calf serum. After incubation the cell
suspension was layered on Ficoll-Paque and cen-
trifuged as described above. The mononuclear cells
were removed, washed twice, and used for cell-
marking studies. These nonrosetting cells are referred
to as non-T cells. The non-T population isolated by
these methods included 50070 B lymphocytes, 30070
monocytes, and <3070 residual T cells. This distribu-
tion was not determined for each preparation.
The monoclonal antibodies used in the study were
83S19.23 and 256S.10. They were produced in re-
sponse to immunization of mice with non-T cells
from peripheral blood of individuals with a history
of RF and were prepared in the Pharmaceuticals Re-
search Department, Ciba-Geigy, Ltd. (Basel, Swit-
zerland). These antibodies have specificity similar
to that of the human alloantisera previously shown
to react with the B cells of individuals with a history
of RF [1, 2].
The study was conducted in two annual visits to
Cairo. In one year the cell surfaces were stained by
an indirect immunofluorescence technique, and in
the other year an immunoperoxidase technique was
used.
Indirect immunofluorescence staining was done
by a method similar to that described by Abramson
et al. [6]. For each non-T sample of tonsil and blood,
three aliquots were stained: monoclonal antibodies
83S19.23 and 256S.10 and a control for determina-
tion of nonspecific adsorption. The slides were care-
fully labeled with a code and read in a blinded man-
Tissue, group,
Monoclonal antibody
antibody reactivity 83S19.23 256S.1O
Blood
RHD
Positive 2.7 ± 0.44 (13) 2.1 ± 0.54 (4)
'}Negative 1.4 ± 0.24 (12) 0.8 ± 0.21 (21)
Control
Positive 4.9 ± 2.2 (4) ... (0) }Negative 0.6 ± 0.17 (16) 0.6 ± 0.20 (20)
Tonsils
RHD
Positive ... (0) ... (0) }Negative 0.26 ± 0.11 (6) 0.08 ± 0.08 (6)
Control
Positive 2.5 ± 0.5 (4) 2.6 ± 0.57 (3) }Negative 0.5 ± 0.3 (14) 1.0 ± 0.49 (15)
Nonspecific binding
1.3 ± 0.25 (25)
0.9 ± 0.21 (20)
o(6)
1.1 ± 0.65 (18)
NOTE. Data are mean ± SE percentages of positive cells (no. of individuals).
Cell Surfaces in RHD
Table 2. Immunoperoxidase assay of "rheumatic" cells.
Tissue, group,
Monoclonal antibody
antibody reactivity 83S19.23 256S.1O
Blood
RHD
Positive 5.9 ± 0.65 (15) 5.2 ± 0.8 (7) }Negative 2.4 ± 0.1 (2) 2.6 ± 0.3 (10)
Control
Positive 9.3 ± 0.25 (2) 10.3 (1) }Negative 1.5 ± 0.2 (19) 1.4 ± 0.14 (20)
Tonsils
RHD
Positive ... (0) ... (0) }Negative 1.1±0.3(11) 1.3 ± 0.26 (11)
Control
Positive 5.7 ± 2.5 (3) 6.7 ± 2.6 (7) }Negative 1.7 ± 0.35 (19) 1.9 ± 0.34 (15)
NOTE. Data are mean ± SE percentages of positive cells (no. of individuals).
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Nonspecific binding
1.9 ± 0.3 (17)
2.1 ± 0.2 (21)
1.3 ± 0.32 (11)
1.4 ± 0.26 (22)
nero An individual was regarded as "positive" for a
given monoclonal antibody if the proportion of cells
binding the monoclonal antibody was significantly
(P < .05 by '1} analysis) greater than the proportion
of cells binding the serum control. Sufficient num-
bers of cells were counted so that the probability «(3)
of not detecting a difference of ~1 070 was <.10 (range
of cells counted, 200-1,800).
A summary of the results obtained with the im-
munofluorescence method is shown in table 1. The
data represent mean values of the staining results and
illustrate the background staining obtained with this
method and the differences between positive and
negative groups. The technique detects the binding
of monoclonal antibodies to only a small fraction
of non-T cells, but the group of positive individuals
clearly have a higher proportion of these cells than
do the negative groups, which are indistinguishable
from the nonspecific serum control. The percentages
of labeled cells in the positive RHD groups are not
significantly different from those in the positive con-
trol groups.
The immunofluorescence method requires that
slides be read soon after preparation, and so that
this limitation on the study of increased numbers
of samples was overcome, an immunoperoxidase
staining method was developed. Immunoperoxidase
staining was accomplished by the avidin-biotin com-
plex method with a kit from Vector Laboratories
(Burlingame, Calif) [7, 8]. The non-T cells were
spread on carefully labeled glass slides, and a circle
rv2 em in diameter was inscribed around the cells,
which were allowed to dry overnight. The slides were
immersed in 95070 ethanol for 5 min, allowed to dry,
and then immersed in PBS (pH 7.4) for 10 min. The
slides were blotted dry around the circles containing
the cells, 30 J..lI of diluted horse serum was added to
the circles, and the slides were incubated at room tem-
perature ("-123 C) in a humid chamber for 30 min
so that nonspecific binding of immunoglobulin was
blocked. They were then immersed in PBS for 10min
and blotted, and 30 J..lI of diluted monoclonal anti-
body was added. After incubation for 30 min the
slides were washed again in PBS and blotted, and
30 J..lI of biotin-labeled antiserum to mouse im-
munoglobulin was added. After incubation for 30
min and a wash in PBS, 30 J..lI of biotin-avidin-
peroxidase solution was added and incubated for 30
min. After a PBS wash and blotting, 50 J..lI of di-
aminobenzidine-hydrogen peroxide substrate was
added, and the slides were incubated for 10min. They
were then washed in distilled water and dried. Con-
trol slides were similarly stained without monoclonal
antibody. The dried slides were transported to the
University of Minnesota Medical School (Min-
neapolis) and read in a blinded and coded manner.
Positive cells were those with black granules around
a greater part of their periphery. A slide was consid-
ered positive when it had a significantly greater num-
ber of positive cells than did the horse serum con-
trol slide, as determined by 'Y} analysis.
Table 2 summarizes the immunoperoxidase results
and illustrates the higher proportion of monoclonal
antibody-binding cells in positive individuals, as
250






83S19.23 67 (28/42)* 17 (7/41)
256S.1O 26 (11142)* 5 (2141)
83S19.23 or 256S.1O 71 (30/42)* 17 (7/41)
83S19.23 and 256S.1O 21 (9/42)* 5 (2/41)
Tonsils
83S19.23 0 (0121)tt 20 (8/40)
256S.1O 0 (0121)H 38 (15/40)§
83S19.23 or 256S.1O 0 (0121)tt 50 (20/40)§
83S19.23 and 256S.1O 0 (0121)t 8 (3/40)
NOTE. Data are percentages (no. of subjects positive/no.
tested).
* Significantly different from control subjects (P < .02).
t Significantly different from control subjects (P < .03).
t Significantly different from blood from individuals with
RHO (P < .02).
§ Significantly different from blood from control subjects (P
< .002).
compared with the immunofluorescence method.
With the immunoperoxidase method the proportion
of labeled cells in individuals considered negative is
not significantly different than the proportion in
slides with nonspecific serum instead of monoclonal
antibody.
Although the percentage of reactive cells detected
by the two methods differed, the proportion of in-
dividuals with or without these cells was not signifi-
cantly different in the two years of the study. There-
fore the data on individuals from the two years were
pooled for analysis.
Results
Cell surface labeling ofperipheral blood non-T
cells. Most individuals with RHD had peripheral
blood non-T cells, with antigenic structures identi-
fied by the monoclonal antibodies 83S19.23 and
256S.10 (table 3). A significantly lower proportion
of the control subjects had non-T cells bearing these
epitopes in their peripheral blood (P < .02). In both
the RHD and control groups, most of the positive
individuals had cells reacting with antibody
83S19.23, and fewer had cells reacting with antibody
256S.10. Cells marked by this latter antibody were
most frequently present in individuals with cells also
marked by antibody 83S19.23. These antibodies evi-
dently are to a cell surface structure commonly pres-
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ent on the peripheral blood mononuclear cells of in-
dividuals with RHD.
Cell surface labeling oftonsillar non-Tcells. In
remarkable contrast to the results with peripheral
blood, the non-T cells from tonsils of individuals
with RHD were not labeled by antibody 83S19.23
or 256S.10 (table 3). None of the 21 subjects with
RHD possessed tonsillar non-T cells with cell sur-
faces identified by these antibodies. However, the
tonsils of 50070 of the control subjects contained cells
reactive with these antibodies. Furthermore, most of
the positive subjects possessed cells marked by anti-
body 256S.10rather than antibody 83S19.23, as seen
in peripheral blood. Clearly, in both the RHD and
control groups, the populations of non-T cells pres-
ent in tonsils are different than those in peripheral
blood.
Relation between blood and tonsils in individu-
als. Both blood and tonsils were studied from 17
individuals with RHD and from 34 individuals with-
out RHD. This approach permitted a comparison
between the blood and tonsils of each of these indi-
viduals for the presence or absence of a significant
proportion of monoclonal antibody-labeled non-T
cells. An individual's blood or tonsil was considered
"positive" if it contained a significantly greater
proportion of non-T cells binding either or both
monoclonal antibodies than did their serum controls.
Each of these individuals could therefore have posi-
tive tonsillar non-T cells, positive blood non-T cells,
or positive non-T cells in both compartments or in
neither compartment. Table 4 shows the unexpected
and highly significant (P < .001) difference between
the RHD group and the control group in the distri-
bution of positive non-T cells between blood and ton-
sils. Individuals whose blood was positive for the
"rheumatic" antigens identified by these monoclonal
antibodies were much more likely to be in the RHD
group (P< .005, q> coefficient = 0.39; table 5). How-
Table 4. Distribution of non-T cells bearing "rheumat-
ic" antigens in blood and tonsils.
Study Blood + Blood + Blood - Blood-
group tonsils - tonsils + tonsils - tonsils + Total
RHO 14 0 3 0 17
Control 3 1 19 11 34
NOTE. Data are no. of subjects. These results are a sum-
mary of those obtained from individuals whose blood and ton-
sils were both studied. The difference between the RHD and
control groups was significant (X2 = 28.2, P < .001).
Cell Sur/aces in RHD





group Positive Negative Positive Negative
RHO 14 3 0 17
Control 4 30 12 22











NOTE. Data are no. of subjects.
* X2 = 24.7, P < .001; q> coefficient for RHO if blood was positive = 0.70.
t X2 = 7.8, P = .005; q> coefficient for RHD if tonsils were negative = 0.39.
t X2 = 18.1, P < .001; q> coefficient for RHO if blood was positive and tonsils were negative = 0.80.
ever, those individuals whose blood non-T cells bore
the "rheumatic" antigens and whose tonsillar non-T
cells did not were the most likely to be in the RHO
group. Those individuals whose tonsillar cells were
positive and whose blood did not contain positive
cells were most likely to be in the group without RHO
(P < .001, q> coefficient = 0.80; table 5).
Discussion
The presence of particular antigens on the surface
of non-T cells in individuals with RF or RHD has
been observed in populations as disparate as those
in India, the United States, and Egypt [3, 9]. These
cell surface structures are characteristically found in
most individuals with this form of disease after strep-
tococcal infection. Their molecular characteristics
and function are not well defined, but as they may
represent expression of la-like genes [1], they might
play a role in the altered immune responses as-
sociated with RF and RHD [4, 5, 10]. The present
study does not permit conclusions regarding the
functional role of these non-T cells bearing "rheu-
matic" antigens. However, other studies have shown
that non-T cells are a requirement for a T celllym-
phoproliferative response to some group A strep-
tococcal products [5]. Moreover, subjects with RHO
from a similar population have an altered function
of blood and tonsillar non-T cells that results in lower
T cell proliferation. These individuals also have lower
relative rates of T suppressor/cytotoxic cell (T8)
proliferation and higher T4/T8 cell ratios after stim-
ulation of their tonsillar cells by streptococcal blasto-
gen A [11]. The relation between these altered im-
mune responses and the "rheumatic" non-T cells may
be involved in the pathogenesis of RHD.
In the population studied here, the presence of
non-T cells bearing the "rheumatic" antigens in the
blood and their absence in the same individual's ton-
sils were most strongly associated with RHD. In con-
trast, the absence of non-T cells bearing the "rheu-
matic" antigens in the blood and their presence in
the same individual's tonsils were most strongly as-
sociated with an absence of RHO. These relations
were observed even though the control group expe-
rienced more pharyngitis than did the RHO group.
Because both groups showed no acute signs of in-
flammation, it seems likely that the differences in
compartmentalization were not due to acute changes
in the tissue distribution of non-T cells. Possibly the
differences were due to an underlying genetic differ-
ence alone or in combination with environmental
factors. The current study groups were selected be-
cause both groups had ample time (mean age, 10
years) and exposure that made repeated pharyngitis
due to group A streptococci very likely. This situa-
tion was important for identification of the associ-
ation of potential immunocyte markers with RHO
because streptococcal pharyngeal infections are
necessary for the expression of a propensity to RHO.
The quantitation of RHO risk associated with these
monoclonal antibody markers will be best defined
by a prospective study from infancy in populations
at high risk for RHO.
One of the most important and apparently abso-
lute determinants for the development of RF and
RHO after group A streptococcal infection is that the
infection take place in the upper respiratory tract [12].
Among the local factors that must be considered to
explain this observation is the role of the tonsils and
related pharyngeal lymphoid tissue. It is possible that
the tonsils may be the focus of immunologic aber-
rations that lead to the development of disease after
streptococcal infection. However, the composition
of the freshly isolated mononuclear cell populations
with respect to B cells, total T cells, or helper and
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suppressor T cell subsets is not significantly altered
in the tonsils of individuals with RHD [11].
The homing of intestine-associated B lymphocytes
to the mammary glands during pregnancy is well
documented [13-15]. This homing is most likely de-
pendent on B cell surface characteristics, with those
B lymphocytes bearing antibody specific for anti-
gens delivered to the maternal intestine and emigrat-
ing to the breast. It is possible that individuals are
put at increased risk for the development of RF and
RHD if appropriate non-T cells have not homed to
the pharyngeal lymphoid tissue before or during epi-
sodes of group A streptococcal pharyngitis.
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